Answers are grounded in this paper and cite their sources.
Background Sarcopenia is associated with adverse outcomes in established liver disease, but its prospective associations with subsequent liver outcomes and the associated circulating proteomic features remain incompletely characterized. Aims To examine the prospective associations of sarcopenia with incident liver outcomes, develop a proteomics-derived sarcopenia score (ProSS), evaluate its predictive value, and explore associated biological pathways. Methods A two-phase analysis was conducted in the UK Biobank. In 492,305 participants, multivariable Cox models assessed the associations of sarcopenia with incident liver outcomes. In a proteomic subcohort of 51,637 participants, ProSS development and internal validation were conducted within a nested five-fold cross-validation framework incorporating multivariable screening, bootstrap-based LASSO, and elastic-net modelling. The incremental prognostic value of ProSS for MASLD and cirrhosis was evaluated using pooled out-of-fold predictions from six Cox models. Functional enrichment and exploratory single-protein indirect-effect analyses were also performed. Results During a median follow-up of approximately 14 years, sarcopenia was associated with higher risks of incident MASLD (HR 1.37, 95% CI 1.26–1.48), cirrhosis (HR 1.58, 95% CI 1.39–1.79), liver cancer (HR 1.86, 95% CI 1.37–2.52), and liver-related mortality (HR 1.91, 95% CI 1.53–2.38). In cross-validation analyses, fold-specific out-of-fold ProSS values were associated with incident MASLD (HR 1.49 per 1-SD increase, 95% CI 1.38–1.61) and cirrhosis (HR 2.39, 95% CI 2.15–2.65). Adding ProSS to a clinical model containing sarcopenia status increased the 10-year AUC from 0.765 to 0.788 for MASLD (ΔAUC 0.023, 95% CI 0.014−0.033; P < 0.001) and from 0.780 to 0.846 for cirrhosis (ΔAUC 0.067, 95% CI 0.043−0.091; P < 0.001). Enrichment analyses highlighted immune and inflammatory signalling, extracellular matrix organization, and cytokine/receptor-related pathways. Exploratory indirect-effect analyses highlighted GDF15, IGFBPL1, and BST2 as the leading protein signals for both MASLD and cirrhosis. Conclusions Sarcopenia was prospectively associated with higher risks of multiple liver outcomes. ProSS provided incremental prognostic information beyond clinical factors and sarcopenia status, particularly for cirrhosis, while the associated circulating proteins may provide biological context for these associations.
No takes yet. Share an insight, caveat, or question.
Liang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: